• Title/Summary/Keyword: Sweet Bee

Search Result 85, Processing Time 0.022 seconds

Study of four weeks repeated-dose toxic test of Sweet Bee Venom in rats Original Articles (Sweet Bee Venom의 rat를 이용한 4주 반복 근육시술 독성시험)

  • Kwon, Hae-Yon;Kwon, Ki-Rok
    • Journal of Pharmacopuncture
    • /
    • v.14 no.1
    • /
    • pp.5-24
    • /
    • 2011
  • Objective: This study was performed to analyse four weeks repeated -dose toxicity of Sweet Bee Venom (SBV-pure melittin, the major component of honey bee venom) in rats. Methods: All experiments were conducted under the regulations of Good Laboratory Practice (GLP) at Biotoxtech Company, a non-clinical study authorized institution. Male and female rats of 5 weeks old were chosen for the pilot study of four weeks repeated-dose toxicity and was injected at the level of 0.56 mg/kg body weight (eighty times higher than the clinical application dosage as the high dosage), followed by 0.28 and 0.14 mg/kg as midium and low dosage, respectively. Equal amount of normal saline was injected as the control group every day for four weeks. Results: 1. No mortality was witnessed in all of the experiment groups. 2. All experiment groups appealed pain sense in the treating time compared to the control group, and side effects such as hyperemia and movement disorder were observed around the area of injection in all experiment groups, and the higher dosage in treatment, the higher occurrence in side effects. 3. Concerning weight measurement, neither male nor female groups showed significant changes compared to the control group. 4. Concerning to the CBC and biochemistry, all experiment groups didn't show any significant changes compared to the control group. 5. Concerning weight measurement of organs, experiment groups didn't show any significant changes compared to the control group. 6. To verify abnormalities of organs and tissues, those such as cerebellum, cerebrum, liver, lung, kidney, and spinal cords were removed and we conducted histologocal observation with H-E staining. Concerning the histologocal observation of liver tissues, some fatty changes were observed around portal vein in 0.56 mg/kg experiment group. But another organs were not detected in any abnormalities. 7. The proper high dosage of SBV for the thirteen weeks repeated test in rats may be 0.28 mg/kg in one time. Conclusion: Above findings suggest that SBV is relatively safe treatment medium. Further studies on the subject should be conducted to yield more concrete evidences.

Correlation between the Constitution of Sasang and Sexual Difference in the Hypersensitive Reaction of Sweet Bee Venom

  • Lee, Kwang-Ho
    • Journal of Pharmacopuncture
    • /
    • v.15 no.3
    • /
    • pp.45-47
    • /
    • 2012
  • Objectives: The aim of this study is to investigate the correlation between the constitution of Sasang and the bee venom hypersensitive reaction, as well as the hypersensitive reaction occurrence ratio between males and females, for patients treated with sweet bee venom (SBV) and who had undergone an examination of the constitution of the Sasang. Methods: All 81 patients enrolled in the study were treated with SBV and underwent an examination of the constitution of Sasang from January 2010 to July 2012. We divided them into two groups for the hypersensitive reaction and no response and compared the distributions of the Sasang-constitution types for the two groups as well as the hypersensitive reaction occurrence ratio between males and females. Results: No significant differences were found between the hypersensitive-reaction group and the no-response group (p = 0.390), but the hypersensitive-reaction occurrence ratio was statistically higher in females than in males (p = 0.001). Conclusions: Hypersensitive reactions do not seem to be related to the Sasang-constitution types, but the possibility of hypersensitive reactions among females seems to be higher than it is among males.

Comparison of the Efficacy between Method of Regulating Ascending Kidney Water and Descending Heart Fire and Sweet Bee Venom Pharmacopuncture on Peripheral Facial Paralysis (말초성 안면신경마비에 대한 수화조절법과 SBV약침치료의 효능비교)

  • Lee, Chang-Hwan;Ku, Ji-Young;Park, Jung-Ah;Lee, Yoo-Hwan;Jang, Kyung-Jeon;Song, Choon-Ho;Kim, Cheol-Hong;Youn, Hyoun-Min
    • Journal of Acupuncture Research
    • /
    • v.28 no.4
    • /
    • pp.85-92
    • /
    • 2011
  • Objectives : This study was designed to compare the effect between method of regulating ascending kidney water and descending heart fire and sweet bee venom pharmacopuncture on peripheral facial paralysis. Methods : We investigated 30 cases of patient with peripheral facial paralysis who visited at Dept. of Acupuncture & Moxibustion, of Oriental Medicine Dong-eui University from November 29, 2010 to May 15, 2011. Subjects were divided randomly into two groups, group A and group B. We applied method of regulating ascending kidney water and descending heart fire twice or three times a week for group A and sweet bee venom pharmacopuncture with same cycle for group B. We measured the effect of treatment to each group five times by using Yanagihara's unweighed grading system. at first examination, after 1 week, 2 weeks, 3 weeks, and 4 weeks. Results : Both groups showed significant improvement in Yanagihara's scores. And group A was improved better than group B for two weeks from the first examination significantly. But after one week from then, the Yanagihara's scores of group B were higher than those of group A significantly. There were no significant differences during other period. Conclusions : Method of regulating ascending kidney water and descending heart fire is more effective than sweet bee venom pharmacopuncture on peripheral facial paralysis during acute period. And after acute period, sweet bee venom pharmacopuncture is more effective than method of regulating ascending kidney water and descending heart fire.

Comparison of the Efficacy between Needle-embedding Therapy and Sweet Bee Venom Pharmacopuncture Therapy on Peripheral Facial Paralysis (말초성 안면신경마비에 대한 매선요법과 SBV 약침치료의 효능 비교)

  • Kim, Jung Hee;Jeong, Jae Yeob;Lee, Seoung Whon;Shin, So Yeon;Park, Jae Heung;Kim, Cheol Hong;Jang, Kyung Jeon;Song, Choon Ho;Yoon, Hyun Min
    • Journal of Acupuncture Research
    • /
    • v.30 no.4
    • /
    • pp.35-44
    • /
    • 2013
  • Objectives : This study was designed to compare the effect between needle-embedding therapy and sweet bee venom pharmacopuncture therapy on early stage of peripheral facial paralysis. Methods : We investigated 60 patients with peripheral facial paralysis. Subjects were randomly divided into two groups and dropped out 20 patients. : needle-embedding therapy group(group A, n=20, dropped out 9 cases among 29 cases) and sweet bee venom pharmacopuncture therapy group(group B, n=20, dropped out 11 cases among 31 cases). needle-embedding therapy was performed for group A three times a week dividing face into three areas during 4 weeks and Sweet bee venom pharmacopuncture therapy was performed for group B two or three times a week during 4 weeks. To evaluate the effect of treatment applied for two groups, we used Yanagihara's unweighed grading system and House-Brachmann grading system at before treatment, after one week from visit, two weeks from visit, three weeks from visit, and four weeks from visit. Results : After treatment, Yanagihara's score and House-Brachmann grading system were improved in each group except during first week. But there was no significant difference in improvement between group A and group B. Conclusions : Needle-embedding therapy would be as effective to improve symptoms of early stage of peripheral facial paralysis as sweet bee venom pharmacopuncture therapy.

A Study of the Initial Dose of Sweet Bee Venom for the Treatment of Patients with Lower Back Pain

  • Lee, Kwang Ho
    • Journal of Acupuncture Research
    • /
    • v.37 no.3
    • /
    • pp.173-176
    • /
    • 2020
  • Sweet bee venom (SBV) causes less hypersensitivity reactions compared with whole bee venom. To determine the appropriate SBV initial dose for pharmacopuncture treatment of lower back pain, the initial dose, and the dose which caused hypersensitivity were retrospectively reviewed between January 1st, 2017 and December 31st, 2019. There were 523 first-visit patients who received SBV pharmacopuncture for lower back pain and 41 showed hypersensitivity. No systemic reactions were observed and localized reactions were not severe. Hypersensitivity was observed during the first (7 cases), and fifth treatments (8 cases). An initial SBV (10%) volume of 0.1 mL was used in 2 cases, 0.2 mL in 6 cases, 0.6 mL in 41 cases, and 1.2 mL in 474 cases. The hypersensitivity rate during the first and fifth treatment was 1.34% and 1.53%, respectively. As a result, 1.2 mL of SBV was considered the acceptable initial dose. However, for safer treatment, we recommend limiting the initial dose of SBV to 0.5 mL.

Clinical Analysis about Treatment of Myofascial Pain Syndrome(MPS) with Sweet Bee Venom on Hand Paresthesia based on Thoracic Outlet Syndrome (흉곽출구증후군으로 손 저림을 호소하는 환자들에 대한 Sweet BV의 아시혈적 치료 효능 관찰)

  • Oh, Sung-Won;Kim, Byoung-Woo;An, Joong-Chul;Yoon, Hye-Chul;Park, Jae-Seuk;Kwon, Ki-Rok
    • Journal of Pharmacopuncture
    • /
    • v.13 no.2
    • /
    • pp.85-92
    • /
    • 2010
  • Objectives: The objective of this study was to compare the effects of Sweet Bee Venom(Sweet BV) Therapy between the hand paresthesia patients with Osteoporosis and without Osteoporosis. Methods: This study was carried out to established the clinical criteria of hand parethesia. The patients who had past history of diabeics, neuropathy induced by alcohol or drug and was positive on Myofacial Pain Syndrome Theory were excluded. 32 patients who had hand paresthesia related with unknown-reason was selected by the interview process. And the effects of treatment were analyzed using VAS score before treatment, after treatment, after 1 month and after 3 months. Results and conclusion: After treatment, While Osteoporosis group decrease from $64.81{\pm}7.81$ to $27.21{\pm}7.32$, Non-Osteoporosis group decrease from $58.76{\pm}1.43$ to $24.74{\pm}3.81$ by VAS scores. and After 3 months, While Osteoporosis group increase from $27.21{\pm}7.32$ to $54.96{\pm}9.40$, Non Osteoporosis group increase from $24.74{\pm}3.81$ to $32.43{\pm}5.57$. Non-Osteoporosis group was accordingly more effective than Osteoporosis group after 3 months. So Sweet BV therapy for hand numbness patients without Osteoporosis was e effective than patients with Osteoporosis.

The comparison of Effectiveness between Bee Venom and Sweet Bee Venom Therapy on Chronic Lower Back Pain. (만성요통환자에 대한 Bee Venom과 Sweet Bee Venom의 치료효능 비교 연구)

  • Kim, Jae-Hong;Jang, Sun-Hee;Yoon, Hyun-Min;Jang, Kyung-Jun;Ahn, Chang-Beohm;Kim, Cheol-Hong;Song, Choon-Ho;Choi, Han-Na
    • Journal of Pharmacopuncture
    • /
    • v.11 no.4
    • /
    • pp.15-24
    • /
    • 2008
  • Objective The aim of this study is to investigate if Sweet Bee Venom(SBV) Therapy has the equal effect in comparison with Bee Venom (BV) Therapy on Chronic Lower Back Pain. Methods Clinical studies were conducted to 39 patients who were treated Chronic Lower Back Pain in Dept. of Acupuncture and Moxibustion, Dongeui University from March 1 to June 30, 2008. Subjects were randomly devided into 2 groups : BV treated group(Group A, n=19), SBV treated group(Group B, n=20) In BV treated group(Group A), we treated patients with dry needle acupuncture and BV Therapy. In SBV treated group(Group B), we treated patients with dry needle acupuncture and SBV Therapy. All process of treatment were performed by double blinding method. 1. To estimate the efficacy of venom in controlling pain, we have checked Visual Analog Scale(VAS). 2. For evaluating functional changes of patients, we have checked Oswestry Lower Back Disability Questionnaire(ODI). 3. To estimate Itching which is the most prominent symptom of allergic reaction, we have checked Visual Analog Scale(VAS). Results 1. In controlling pain, the results of BV treated group(Group A) is more effective than that of SBV treated group(Group B). 2. In promoting function, the results of BV treated group (Group A) is more effective than that of SBV treated group(Group B). 3. In controlling itching, the results of SBV treated group(Group B) is more effective than that of BV treated group(Group A). Conclusions According to the study, SBV Therapy shows more effective result than BV Therapy in controlling itching. But BV Therapy is more effective than SBV Therapy in controlling pain and promoting function.

A Case Report of Patients with Calcific Tendinitis Located at Supraspinatus Treated by Oriental Therapy Including Sweet Bee Venom (봉약침을 포함한 한방치료로 호전된 극상근 석회화 건염 3례)

  • Lee, Yeon-Hee;Kim, Chae-Won;Lee, Kwang-Ho
    • Journal of Acupuncture Research
    • /
    • v.29 no.2
    • /
    • pp.89-97
    • /
    • 2012
  • Objectives : The purpose of this report is to show that oriental medical treatments, chiefly using Sweet bee venom (SBV) are effective on symptom improvements and calcium removal in the patients diagnosed with calcific tendinitis in supraspinatus. Methods : We applied 0.3~0.6cc of SBV on $LI_{15}$ ($Gyeonu$) at a time and 0.1~0.2cc on each surrounding pressure point. In addition, we treated $Hwangryeonhaedok-tang$ pharmacopuncture on both acupoints of $GB_{21}$ ($Gyeonjeong$) with large intestine tonification of $Sa-Am$. Results : The symptoms improved within 3 weeks in case 1, 4 days in case 2, 5 weeks in case 3. The removal of calcium was detected by radiology at all cases. Conclusions : From the above results, it is considered that the oriental medical therapy including SBV is effective on the removal of calcium.

A case report of monitoring PSA level changes in two prostate cancer patients treated with Mountain Ginseng Pharmacopuncture and Sweet Bee Venom along with western anticancer therapy (양방 항암치료와 병행하여 산삼약침과 봉약침 치료를 받은 전립선암 환자들의 PSA 수치 변화 관찰 보고)

  • Lee, Yeon-Hee;Kim, Chae-Won;Lee, Kwang-Ho
    • Journal of Pharmacopuncture
    • /
    • v.14 no.4
    • /
    • pp.81-88
    • /
    • 2011
  • Objectives: The purpose of this report is to find out how Mountain Ginseng Pharmacopuncture(MGP) and Sweet Bee Venom(SBV) treatments are effective on prostate cancer patients by monitoring Prostate specific antigen(PSA) values. Methods: We treated two prostate cancer patients with MGP and SBV from October 2008 to April 2011. One patient had localized prostate cancer, the other was in the terminal stage of prostate cancer with lung and bone metastasis and both had been receiving western anticancer therapy. We had monitored the changes of PSA value. Results: In case 1, MGP and SBV treatments seemed to be helpful in preventing the recurrence of localized prostate cancer. In case 2, PSA value was decreased by MGP treatment. Conclusions: It is conceivable that MGP and SBV are effective treatments for patients with prostate cancer.

Neuroprotective Effects of Bee Venom, which Removes High Molecular Elements against $MPP^+$-induced Human Neuroblastoma SH-SY5Y Cell Death ($MPP^+$로 유도된 SH-SY5Y신경세포 사멸에 대한 고분자성분제거 봉독약침액의 신경보호 효과 연구)

  • Bae, Kwang-Rok;Doo, Ah-Reum;Kim, Seung-Nam;Park, Ji-Yeon;Park, Hi-Joon;Lee, Hye-Jung;Kwon, Ki-Rok
    • The Journal of Internal Korean Medicine
    • /
    • v.31 no.2
    • /
    • pp.254-263
    • /
    • 2010
  • Objectives : The neuroprotective effects of bee venom (BV) have been demonstrated in many studies, but bee venom has many side effects. So we used sweet bee venom (SBV), which has high molecular elements removed to reduce the side effects. I examined the neuroprotective effect of sweet bee venom in 1-methyl-4-phenylpyridine ($MPP^+$)-induced human neuroblastoma SH-SY5Y cells. Methods : To observe the possible toxicity of SBV itself, SH-SY5Y cells were treated with SBV in various concentrations for 3 h and $MPP^+$ in concentrations (1 and 5mM) for 24h. To investigate the protective effect of SBV against $MPP^+$ toxicity, SH-SY5Y cells were pretreated with vehicle or nontoxic concentrations of SBV for 3h and the cells were not washed, followed by incubation with respective concentrations of SBV and 1 mM $MPP^+$ for 24h. To investigate the protective effect of SBV against $MPP^+$ toxicity, SH-SY5Y cells were pretreated with vehicle or nontoxic concentrations of SBV for 3h and the cells were not washed, followed by incubation with respective of SBV(0.5%), 1 mM $MPP^+$, 5uM AKT inhibitor(LY984002) and 10uM ERK inhibitor(PD98059) for 24 h. The protective effect was measured by cell viability assay. To investigate the degree of apoptosis, caspase-3 enzyme activity was measured in control, $MPP^+$, SBV+$MPP^+$. Results : SBV (0.5%) pretreatment protected the SH-SY5Y cells against $MPP^+$-induced apoptotic cell death. The cell viability was higher in the SH-SY5Y cells that were pretreated with vehicle or nontoxic concentrations of SBV than those not pretreated. The caspase-3 activity was lower in the pretreated groups than these not pretreated. ERK and AKT enzymes have a role in the neuroprotective effects of the sweet bee venom. Conclusions : The results demonstrate that SBV has a protective effect on dopaminergic neurons against $MPP^+$ toxicity. This data suggest that SBV could be a potential therapeutic tool for neurodegenerative diseases such as Parkinson's disease(PD).